| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.877 | 31.764 | - | 49.466 | 48.978 | 31.481 | 43.978 | 34.283 | 46.536 | 32.688 |
| Total Income - EUR | 10.877 | 31.764 | - | 49.466 | 48.978 | 31.481 | 43.978 | 34.283 | 46.536 | 32.688 |
| Total Expenses - EUR | 4.862 | 21.370 | - | 19.472 | 24.313 | 21.725 | 27.360 | 33.031 | 30.166 | 30.834 |
| Gross Profit/Loss - EUR | 6.015 | 10.394 | - | 29.994 | 24.665 | 9.757 | 16.618 | 1.252 | 16.370 | 1.854 |
| Net Profit/Loss - EUR | 5.689 | 9.718 | - | 28.510 | 23.948 | 9.465 | 15.910 | 412 | 15.933 | 1.502 |
| Employees | 0 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vivere Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 11.173 | 8.609 | 6.142 | 4.913 | 1.596 | 1.314 | 1.307 |
| Current Assets | 6.400 | 17.627 | - | 69.036 | 26.437 | 14.203 | 30.052 | 36.199 | 51.589 | 46.819 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.384 | 397 | - | 1.312 | 21.869 | -228 | 20.576 | 20.640 | 45.304 | 42.045 |
| Cash | 4.015 | 17.230 | - | 67.724 | 4.568 | 14.431 | 9.476 | 15.559 | 6.286 | 4.775 |
| Shareholders Funds | 5.734 | 15.393 | - | 68.815 | 26.673 | 12.131 | 27.772 | 28.270 | 44.117 | 45.372 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 665 | 2.234 | - | 11.394 | 8.373 | 8.214 | 7.193 | 9.525 | 8.786 | 2.754 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Vivere Medica S.r.l.